Effectiveness of fibrin sealant after cementless total hip replacement: A double-blind randomized controlled trial

International Journal of Immunopathology and Pharmacology

Volumn 26, Issue 1, 2013, Pages 189-197

  Randelli, F ^a   Banci, Lorenzo ^a   Ragone, V ^a   Pavesi, M ^a   Randelli, G ^a  

^a IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; HEMOGLOBIN;

ADULT; AGED; ARTICLE; CEMENTLESS PROSTHESIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOSTASIS; HUMAN; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TOTAL HIP PROSTHESIS; TREATMENT OUTCOME; DRUG EFFICACY; DRUG SAFETY; HEMATOCRIT; HIP OSTEOARTHRITIS; INTRAOPERATIVE PERIOD;

EID: 84881241343     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201302600118     Document Type: Article

References (32)

1. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007; 107(4):397-401.
2. Ray M, Hatcher S, Whitehouse SL, Crawford S, Crawford R. Aprotinin and epsilon aminocaproic acid are effective in reducing blood loss after primary total hip arthroplasty-a prospective randomized double-blind placebo-controlled study. J Thromb Haemost 2005; 3(7):1421-7. (Pubitemid 41725198)
3. Garneti N, Field J. Bone bleeding during total hip arthroplasty after administration of tranexamic acid. J Arthroplasty 2004; 19(4):488-92. (Pubitemid 38725933)
4. Helm AT, Karski MT, Parsons SJ, Sampath JS, Bale RS. A strategy for reducing blood-transfusion requirements in elective orthopaedic surgery. Audit of an algorithm for arthroplasty of the lower limb. J Bone Joint Surg (Br) 2003; 85(4):484-89. (Pubitemid 36621961)
5. Rashiq S, Jamieson-Lega K, Komarinski C, Nahirniak S, Zinyk L, Finegan B. Allogeneic blood transfusion reduction by risk-based protocol in total joint arthroplasty. Can J Anaesth 2010; 57(4):343-49.
6. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, Cremers S, Abraham IL; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43(4):459-69. (Pubitemid 36428328)
7. Nouwairi NS. The risks of blood transfusions and the shortage of supply leads to the quest for blood substitutes. AANA J 2004; 72(5):359-64.
8. Blumberg N, Kirkley SA, Heal JM. A cost analysis of autologous and allogeneic transfusions in hip-replacement surgery. Am J Surg 1996; 171:124-30.
9. Goodnough LT, Shuck JM. Risks, options, and informed consent for blood transfusion in elective surgery. Am J Surg 1990; 159(6):602-9. (Pubitemid 20180134)
10. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: First of two parts - blood transfusion. N Engl J Med 1999; 340:438-47. (Pubitemid 29084776)
11. Dodd R. The risk of transfusion-transmitted infection. N Engl J Med 1992; 327(2):419-21.
12. Peterman TA, Jaffe HW, Feorino PM, Getchell JP, Warfield DT, Haverkos HW, Stoneburner RL, Curran JW. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA 1985; 254(20):2913-17. (Pubitemid 16205457)
13. Stevens GE, Aach RD, Hollinger FB, Mosley JW, Szmuness W, Kahn R, Werch J, Edwards V. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non- B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101(6):733-38. (Pubitemid 15187359)
14. Spahn DR, Casutt M. Eliminating blood transfusions. New aspects and perspectives. Anesthesiology 2000; 93:242-55. (Pubitemid 30436699)
15. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005; 105(6):2266-73. (Pubitemid 40387018)
16. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998; 86:9-15. (Pubitemid 28040082)
17. Gargaro JM, Walls CE. Efficacy of intraoperative autotransfusion in primary total hip arthroplasty. J Arthroplasty 1991; 6:157-61.
18. Henry DA, Carless PA, Moxey AJ, et al. Preoperative autologous donation for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2002; 2:CD003602.
19. Paul JE, Ling E, Lalonde C, Thabane L. Deliberate hypotension in orthopedic surgery reduces blood loss and transfusion requirements: a meta-analysis of randomized controlled trials. Can J Anesth 2007; 54:799-810. (Pubitemid 47597121)
20. Benoni G, Fredin H. Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg (Br) 1996; 78(3):434-40. (Pubitemid 26158834)
21. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg (Br) 2009; 91(6):776-83.
22. Ekback G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, Carlsson O, Schött U. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg 2000; 91(5):1124-30.
23. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine: Second of two parts - blood conservation. N Engl J Med 1999; 340:525-33. (Pubitemid 29093289)
24. Levy O, Martinowitz U, Oran A, Tauber C, Horoszowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty. A prospective, randomized, multicenter study. J Bone Joint Surg (Am) 1999; 81(11):1580-88.
25. Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg (Br) 2007; 89(3):306-9. (Pubitemid 46563903)
26. Crawford RW, Giangrande P, Murray D. Fibrin sealant reduces blood loss in total hip arthroplasty. Hip Int 1999; 9(3):127-32. (Pubitemid 29476012)
27. Wang GJ, Goldthwaite GAJ, Burks S, Grawford R, Spotnitz WD. Fibrin sealant reduces perioperative blood loss in total hip replacement. J Long Term Eff Med Implants 2003; 13(5):399-411. (Pubitemid 37329082)
28. Lassen MR, Solgaard S, Kjersgaard AG, Olsen C, Lind B, Mittet K, Ganes HC. A pilot study of the effects of Vivostat patient-derived fibrin sealant in reducing blood loss in primary hip arthroplasty. Clin Appl Thromb Hemost 2006; 12(3):352-57. (Pubitemid 44400848)
29. Mawatari M, Higo T, Tsutsumi Y, Shigematsu M, Hotokebuchi T. Effectiveness of autologous fibrin tissue adhesive in reducing postoperative blood loss during total hip arthroplasty: a prospective randomised study of 100 cases. J Orthop Surg (Hong Kong) 2006; 14(2):117-21.
30. Woolson ST, Watt JM. Use of autologous blood in total hip replacement. A comprehensive program. J Bone Joint Surg (Am) 1991; 73:76-80.
31. Billote DB, Glisson SN, Green D, Wixson RL. Efficacy of preoperative autologous blood donation: analysis of blood loss and transfusion practice in total hip replacement. J Clin Anesth 2000; 12(7):537-42. (Pubitemid 32010719)
32. American Society of Anesthesiologists Task Force on. Practice guidelines for perioperative blood transfusion and adjuvant therapies. Anesthesiology 2006; 105(1):198-208.